For the year ending 2025-12-31, BIOA has $294,889K in assets. $22,838K in debts. $188,888K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 188,888 | |||
| Marketable securities, current | 92,210 | |||
| Accounts receivable | 769 | |||
| Prepaid expenses and other current assets | 4,926 | |||
| Total current assets | 286,793 | |||
| Investments | 100 | |||
| Marketable securities | 4,032 | |||
| Property and equipment, gross | 1,445 | |||
| Accumulated depreciation | 482 | |||
| Property and equipment, net | 963 | |||
| Operating lease right-of-use assets | 2,785 | |||
| Other assets | 216 | |||
| Total assets | 294,889 | |||
| Accounts payable | 2,674 | |||
| Accrued expenses and other current liabilities | 8,480 | |||
| Current portion of term loan | 2,648 | |||
| Operating lease liabilities, current | 582 | |||
| Deferred revenue, current | 5,754 | |||
| Total current liabilities | 20,138 | |||
| Deferred revenue | 0 | |||
| Term loan | 0 | |||
| Warrant liability | 370 | |||
| Operating lease liabilities | 2,330 | |||
| Total liabilities | 22,838 | |||
| Additional paid-in-capital | 605,189 | |||
| Accumulated other comprehensive income | 278 | |||
| Accumulated deficit | -333,416 | |||
| Total stockholders' equity | 272,051 | |||
| Total liabilities and stockholders' equity | 294,889 | |||
BioAge Labs, Inc. (BIOA)
BioAge Labs, Inc. (BIOA)